Hämostaseologie, Table of Contents Hamostaseologie 2025; 45(S 01): S85DOI: 10.1055/s-0044-1801674 Abstracts Topics T-10 Platelets – Disorders of platelet function and numbers The Potential of HMB-001 as a Prophylactic Treatment of Glanzmann Thrombasthenia: Interim Analysis of the Phase 2 Study Authors Author Affiliations S Sivapalaratnam 1 Queen Mary University of London, London, UK 2 Barts Health NHS Trust, London, UK L Frenzel 3 Necker Hospital, Paris, France R D’Orion 4 APHP Bicêtre University Hospital, Le Kremlin-Bicêtre, France C Rea 5 Hemab Therapeutics, Cambridge, USA A Gosnell 5 Hemab Therapeutics, Cambridge, USA R Malladi 5 Hemab Therapeutics, Cambridge, USA J Amin 5 Hemab Therapeutics, Cambridge, USA U Lorch 6 Richmond Pharmacology, London, UK M Goricar 6 Richmond Pharmacology, London, UK A Law 5 Hemab Therapeutics, Cambridge, USA Recommend Article Abstract Full Text References References 1 Sivapalaratnam et al. EAHAD 2024; ClinicalTrials.gov. Identifier NCT06211634.
